Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Sarah Timsit und 13 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, AP-HP, Hôpital Saint Louis, Paris, France. Hauptthemen laut MEDLINE: Multiple Myeloma, Parainfluenza Virus 3, Human, Disease Outbreaks, Respirovirus Infections. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Human parainfluenza virus type 3 (HPIV‐3) can be responsible for mild to severe respiratory infections and hospital epidemics. We investigated an outbreak in a hematology unit. Respiratory viruses were screened using multiplex PCR. HPIV‐3 quantification and whole‐genome sequencing were performed on HPIV‐3 positive respiratory samples. Clinical characteristics, infection progression, incidence rates of respiratory viruses within the hospital and detection of respiratory viruses were documented, along with the reinforcement of infection prevention and control (IPC) measures implemented. Between November 2022, and January 2023, HPIV‐3 was identified in 20 of 113 hematology patients (17.7%), of whom 80% had multiple myeloma. A majority of HPIV‐3‐positive patients developed pneumonia (60%), and mortality was notably higher (35%) compared to patients who were negative (3%, p < 0.0001). Respiratory HPIV‐3 viral loads were similar between patients with and without pneumonia. In parallel, HPIV‐3 incidence in the hospital overall was lower than in the hematology unit ( p < 0.0001). Air virus screening showed the detection of HPIV‐3 in the air in different areas, and whole‐genome sequencing confirmed the circulation of a single HPIV‐3 strain. Strengthened IPC measures were associated with the containment of the outbreak. HPIV‐3 has high epidemic potential in patients with multiple myeloma and causes severe infections. Our findings highlight the need for routine HPIV‐3 testing in hematology units.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Virology Department, AP-HP, Hôpital Saint Louis, Paris, France.
- Infection Prevention and Control Unit, AP-HP, Hôpital Saint-Louis, Paris, France.
- IPLESP, INSERM, Sorbonne University, Paris, France.
- Immuno-Hematology Department, AP-HP, Hôpital Saint-Louis, Paris, France.
- Université Paris Cité, Inserm U976, Insight Team, Paris, France.
ORCID-Profile: Sarah Timsit, Maud Salmona, Jérôme Legoff
Zitieren
APA
Timsit, S., Mellon, G., Forgeard, N., Mercier-Delarue, S., Mahjoub, N., Euzen, V., Harel, S., Elessa, D., Osinski, N., Diaz, E., Royer, B., Arnulf, B., Salmona, M., & Legoff, J. (2025). Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.70411
Vancouver
Timsit S, Mellon G, Forgeard N, Mercier-Delarue S, Mahjoub N, Euzen V, et al. Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients. Journal of Medical Virology. 2025. doi:10.1002/jmv.70411
BibTeX
@article{Timsit2025,
author = {Timsit, Sarah and Mellon, Guillaume and Forgeard, Nathalie and Mercier-Delarue, Séverine and Mahjoub, Nadia and Euzen, Victor and Harel, Stéphanie and Elessa, Dikelele and Osinski, Nathalie and Diaz, Elise and Royer, Bruno and Arnulf, Bertrand and Salmona, Maud and Legoff, Jérôme},
title = {Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70411}
}
EUVIMED